Menzies-Gow A, Ponnarambil S, Downie J, Bowen K, et al. DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respir Res 2020;21:279.
PMID: 33087119